KRAS G12C Inhibitors: Acquired Resistance and Combo Strategies
Published: | Updated:
Targeted Oncology
Articles by Targeted Oncology
Targeted Therapy in NSCLC: Improvements in Molecular Testing
Published: | Updated:
Shared insight on recent advances in KRAS-mutant NSCLC, with a focus on new therapies on the horizon.
Case 3: Low- to Intermediate- Risk Essential Thrombocythemia
Published: | Updated:
Case 3: Prediction of Thrombosis in Essential Thrombocythemia
Published: | Updated:
